Back to search

Company profile

NRG THERAPEUTICS LTD

active • ltd • Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, Herts, SG1 2FX, United Kingdom

Company no.11294505Officers16Documents20

Key company facts

Core operating details surfaced from the public profile endpoint.

Company Number
11294505
Company Status
active
Type
ltd
Date Of Creation
2018-04-05
Registered Office
Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, Herts, SG1 2FX, United Kingdom
Sic Codes
research and experimental development on biotechnology

Financials

A cleaner view of the latest filing, balance sheet movement, and multi-year trend.

Total assets

£4.47m

Equity

£2.28m

Total liabilities

£2.19m

Cash in bank

£3.56m

Year-on-year movement

Quick comparison from the latest filed period.

2025-04-30

Equity

-£2.63M

-53.63%

Cash in bank

-£1.69M

-32.26%

Total assets

-£2.23M

-33.34%

Total liabilities

-£398.00k

-22.17%

Financial trend

Multi-year view of the main balance sheet lines.

Net Assets
Total Assets
Total Liabilities
2022202320242025

Latest snapshot

Financial year2025
Statement date2025-04-30
Trade debtors£0
Trade creditors£723,942
Fixed assets£4,812
Current assets£4.46m
YearNet AssetsTotal AssetsTotal Liabilities
2022-£1.16m£505,763-£1.66m
2023£17.61m£0£0
2024£4.91m£6.70m-£1.79m
2025£2.28m£4.47m-£2.19m

Available In The Full Platform

Unlock deeper company intelligence

More company intelligence is available through your account, including premium data, deeper records, and advanced insight.

Locked contact intelligence

Contact Details & Ownership

Reveal verified contact points, shareholder visibility, and group structure signals beyond the public summary.

Locked insight

Sign up or log in to view contact insight

Contact DetailsShareholdersGroup StructureCorporate Network Graph

Locked compliance screening

Risk & Compliance

Access enhanced due diligence signals for KYC, sanctions, adverse media, phoenix risk, and register visibility.

Locked insight

Sign up or log in to access compliance insight

KYC+Adverse Media ScreeningPhoenix Detection SummaryFCA Register

Locked financial insight

Financial Intelligence

Unlock premium financial analysis including credit insight, risk scoring, and AI-assisted valuation signals.

Locked insight

Sign up or log in to unlock financial insight

AI Financial Risk InsightsAI Company ValuationCredit ScoreCharges

Locked filing intelligence

Assets, Filings & Registers

Go beyond the headline profile with deeper asset, filing, register, and notice-level intelligence.

Locked insight

Sign up or log in to explore filing insight

PropertyTrademarkGazette NoticesCharges

Latest activity

Recent company and officer updates, reshaped from the watchlist activity source for public profile use.

UpdateDateRecency
Confirmation Statement Submitted19 Apr 20261 Month
BARKER, Laurence Daniel Paul Resigned2 Feb 20263 Months
JOHNSON, Emma Resigned10 Dec 20255 Months
Accounts Submitted13 Oct 20257 Months
KREMERS, Charlotte Johanna Pauline Appointed22 Aug 20259 Months
ROACH, Arthur Resigned2 Jul 202511 Months
JACKMAN, Katherine Resigned2 Jul 202511 Months
JOHNSON, Emma Appointed2 Jul 202511 Months
BARKER, Laurence Daniel Paul Appointed2 Jul 202511 Months
MUELLERSHAUSEN, Florian, Dr Appointed2 Jul 202511 Months
Confirmation Statement Submitted4 Apr 20251 Year
Accounts Submitted22 Oct 20241 Year

Documents

Public filing documents and direct PDF links where available.

DescriptionDateDocument
confirmation-statement-with-updates2026-04-19Open PDF
capital-allotment-shares2026-02-24Open PDF
termination-director-company-with-name-termination-date2026-02-04Open PDF
appoint-person-director-company-with-name-date2026-02-04Open PDF
termination-director-company-with-name-termination-date2025-12-12Open PDF
accounts-with-accounts-type-small2025-10-13Open PDF
memorandum-articles2025-08-28Open PDF
resolution2025-08-28Open PDF
appoint-person-director-company-with-name-date2025-08-28Open PDF
capital-allotment-shares2025-08-27Open PDF
second-filing-change-details-of-a-person-with-significant-control2025-08-14Open PDF
capital-allotment-shares2025-07-15Open PDF